Alto Neuroscience, Inc. (ANRO) Insider Trading -- Recent Executive & Director Transactions
2 insiders reported 10 Form 4 transactions for Alto Neuroscience, Inc. (ANRO) over the past 18 months (most recent 2026-10-05). Recent activity: Smith Nicholas Conrad (PRESIDENT AND CFO) Buy 55,000 shares, Smith Nicholas Conrad (PRESIDENT AND CFO) Buy 56,455 shares, Smith Nicholas Conrad (PRESIDENT AND CFO) Buy 54,375 shares, Smith Nicholas Conrad (PRESIDENT AND CFO) Sell 110,830 shares, Smith Nicholas Conrad (PRESIDENT AND CFO) Buy 24,056 shares. Source: SEC Form 4.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-10-05 | Smith Nicholas Conrad | PRESIDENT AND CFO | Buy | 55,000 | $127,600 |
| 2026-10-01 | Smith Nicholas Conrad | PRESIDENT AND CFO | Buy | 56,455 | $132,669 |
| 2026-10-01 | Smith Nicholas Conrad | PRESIDENT AND CFO | Buy | 54,375 | $127,781 |
| 2026-10-01 | Smith Nicholas Conrad | PRESIDENT AND CFO | Sell | 110,830 | $2.9M |
| 2026-10-01 | Smith Nicholas Conrad | PRESIDENT AND CFO | Buy | 24,056 | $56,532 |
| 2026-10-01 | Smith Nicholas Conrad | PRESIDENT AND CFO | Sell | 23,170 | $597,290 |
| 2026-10-01 | Smith Nicholas Conrad | PRESIDENT AND CFO | Sell | 886 | $23,807 |
| 2026-05-15 | Etkin Amit | PRESIDENT AND CEO | Sell | 400,000 | $0 |
| 2026-03-03 | Etkin Amit | PRESIDENT AND CEO | Sell | 6,227 | $122,610 |
| 2026-03-03 | Smith Nicholas Conrad | CHIEF FINANCIAL OFFICER & CBO | Sell | 2,806 | $55,250 |
Source: SEC Form 4 filings · as of 2026-10-05